Drug
Vonoprazan
Vonoprazan: highest development phase Post-Market, developed by Takeda. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Takeda
Trials
| Drug | Phase | Indication |
|---|---|---|
| Vonoprazan NCT02679508 | Post-Market | Erosive Esophagitis |
Latest
No recent events.
Follow Vonoprazan on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.